文献速递造血干细胞移植与细胞治疗血栓与止血

移植相关血栓性微血管病预后模型BATAP及外部验证

A prognostic model (BATAP) with external validation for patients with transplant-associated thrombotic microangiopathy.
PubMed 文献 · Blood Adv · 2021-01-01

该研究回顾性纳入507例异基因造血干细胞移植后发生TA-TMA的患者,按移植时间分为推导队列和验证队列进行外部时间验证。年龄、贫血、重度血小板减少、总胆红素升高和蛋白尿被确定为6个月结局的独立预后因素,据此构建BATAP风险评分模型。内部验证c统计量为0.816(95%CI 0.766-0.867),外部验证为0.756(95%CI 0.696-0.817),校准图显示预测概率与实际观察频率相关性良好。

要点

  • BATAP模型基于胆红素、年龄、血小板减少、贫血、蛋白尿五项指标构建。
  • 内部验证c统计量0.816,外部时间验证c统计量0.756。
  • 该模型有助于TA-TMA预后判断和高危患者早期识别。

核心结论

  • BATAP预后模型可用于TA-TMA患者的预后判断,并有助于早期识别高危患者。

研究设计与样本

  • 回顾性识别507例异基因造血干细胞移植后发生TA-TMA的患者,按移植时间分为推导队列和验证队列进行外部时间验证。

主要发现

  • 年龄(OR 2.371;95%CI 1.264-4.445)、贫血(OR 2.836;95%CI 1.566-5.138)、重度血小板减少(OR 3.871;95%CI 2.156-6.950)、总胆红素升高(OR 2.716;95%CI 1.489-4.955)和蛋白尿(OR 2.289;95%CI 1.257-4.168)为TA-TMA 6个月结局的独立预后因素。
  • 根据回归系数构建BATAP风险评分模型。
  • 内部验证c统计量为0.816(95%CI 0.766-0.867),外部验证c统计量为0.756(95%CI 0.696-0.817)。
  • 校准图显示模型预测概率与实际观察频率相关性良好。

关键数值与推荐

  • BATAP模型包含胆红素、年龄、血小板减少、贫血、蛋白尿五项指标。
  • 内部验证c统计量0.816(95%CI 0.766-0.867),外部验证c统计量0.756(95%CI 0.696-0.817)。

临床怎么用

  • 可依据BATAP模型对TA-TMA患者进行风险分层,辅助早期识别高危患者并指导临床决策。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Transplant-associated thrombotic microangiopathy (TA-TMA) is a potentially life-threatening complication following allogeneic hematopoietic stem cell transplantation (allo-HSCT). Information on markers for early prognostication remains limited, and no predictive tools for TA-TMA are available. We attempted to develop and validate a prognostic model for TA-TMA. A total of 507 patients who developed TA-TMA following allo-HSCT were retrospectively identified and separated into a derivation cohort and a validation cohort, according to the time of transplantation, to perform external temporal validation. Patient age (odds ratio [OR], 2.371; 95% confidence interval [CI], 1.264-4.445), anemia (OR, 2.836; 95% CI, 1.566-5.138), severe thrombocytopenia (OR, 3.871; 95% CI, 2.156-6.950), elevated total bilirubin (OR, 2.716; 95% CI, 1.489-4.955), and proteinuria (OR, 2.289; 95% CI, 1.257-4.168) were identified as independent prognostic factors for the 6-month outcome of TA-TMA. A risk score model termed BATAP (Bilirubin, Age, Thrombocytopenia, Anemia, Proteinuria) was constructed according to the regression coefficients. The validated c-statistic was 0.816 (95%, CI, 0.766-0.867) and 0.756 (95% CI, 0.696-0.817) for the internal and external validation, respectively. Calibration plots indicated that the model-predicted probabilities correlated well with the actual observed frequencies. This predictive model may facilitate the prognostication of TA-TMA and contribute to the early identification of high-risk patients.

来源:Blood Adv,查看原文。版权归原作者所有。

引用

  1. Zhao P, Wu YJ, He Y, et al. A prognostic model (BATAP) with external validation for patients with transplant-associated thrombotic microangiopathy. Blood Adv. 2021. PMID: 34507352. doi:10.1182/bloodadvances.2021004530

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。